Retina specialty practices are among the highest-volume clinical environments in all of medicine. A single retina specialist may perform 30 to 60 intravitreal injections per day, with patients returning for treatment every four to twelve weeks depending on their disease protocol. The American Society of Retina Specialists (ASRS) reported in its 2022 global trends survey that anti-VEGF injection volume in the United States continues to grow year over year, driven by the aging population and increasing prevalence of diabetic retinopathy and age-related macular degeneration (AMD).
That injection volume brings with it a corresponding volume of prior authorization requests, patient scheduling demands, and insurance verification requirements — all of which must be managed accurately to keep the injection schedule running without gaps. Virtual assistants are proving essential to retina practices that want to scale their injection programs without proportionally scaling their administrative headcount.
Anti-VEGF Injection Authorization Management
Anti-VEGF agents — ranibizumab (Lucentis), aflibercept (Eylea), bevacizumab (Avastin), and faricimab (Vabysmo) — are among the most frequently administered specialty medications in ophthalmology. They are also among the most frequently prior-authorized. Commercial payers and Medicare Advantage plans require documentation of diagnosis, visual acuity, optical coherence tomography (OCT) findings, and often step-therapy attestation before approving treatment.
For patients receiving injections every four to six weeks, that authorization must be renewed regularly — sometimes every three months, sometimes every six months, depending on the payer. A virtual assistant dedicated to injection authorization can track the renewal schedule for each patient, submit renewals before the current authorization expires, and follow up on pending approvals to ensure no patient misses a treatment due to a lapsed authorization.
The ASRS has estimated that authorization delays are among the top operational challenges cited by retina specialists, with some practices reporting treatment delays of two to four weeks due to unmanaged authorization lapses.
High-Volume Scheduling and Patient Recall
Managing a recall schedule for an injection patient panel is operationally demanding. Patients need to be contacted at the appropriate interval, their scheduling preferences accommodated, and their appointment confirmed before the day of treatment. For a practice with 500 or more active injection patients, this recall function is effectively a full-time job.
A virtual assistant can own the patient recall workflow: generating outreach for patients due for their next injection, confirming appointments, handling rescheduling requests, and sending pre-appointment reminders. This systematic approach to recall reduces the percentage of patients who fall off their treatment schedule — a clinically important outcome in a specialty where treatment gaps are associated with vision loss.
Insurance Verification and Benefit Coordination
Retina practices commonly see patients with complex insurance coverage: Medicare primary, commercial supplemental, and sometimes Medicaid. Verifying benefits for each patient, confirming covered diagnoses, and identifying cost-sharing responsibilities before the visit prevents billing surprises and reduces claim rejections.
A VA can verify insurance eligibility for each scheduled patient, confirm that the planned medication is covered under the patient's current authorization, and communicate any benefit changes to the front desk before the appointment. For practices administering branded anti-VEGF agents, confirming that the specific product administered matches the authorization on file is a compliance function that a dedicated VA can manage systematically.
Patient Communication and Education Support
AMD and diabetic retinopathy patients are often elderly and may have limited familiarity with the healthcare system. Consistent communication — appointment reminders, instructions for the day of injection, post-procedure care guidance — reduces no-shows and improves the patient experience in a clinical setting that can feel intimidating.
Virtual assistants handle this communication layer efficiently, sending automated reminders, making personal confirmation calls for high-risk no-show patients, and responding to common patient questions. Practices looking to optimize their injection program operations can explore VA services at Stealth Agents, where trained healthcare VAs support ophthalmology workflows including recall scheduling, authorization management, and patient communication.
For retina specialty practices, the administrative infrastructure surrounding the injection program is not secondary to clinical operations. It is the mechanism by which patients receive treatment on time — and in a specialty where treatment timing affects vision, that infrastructure is critical.
Sources
- American Society of Retina Specialists (ASRS), Global Trends in Retina Survey, 2022
- American Academy of Ophthalmology, Age-Related Macular Degeneration: A New Treatment Paradigm, 2023
- Centers for Medicare & Medicaid Services (CMS), Part B Drug Coverage and Prior Authorization, 2023